Incidence and Risk Factors of Lower-Extremity Lymphedema After Radical Surgery With or Without Adjuvant Radiotherapy in Patients With FIGO Stage I to Stage IIA Cervical Cancer. Issue 4 (1st May 2012)

• Record Type: Journal Article
• Authors: Kim, Jin Hwi; Choi, Ji Hyang; Ki, Eun Young; Lee, Sung Jong; Yoon, Joo Hee; Lee, Keun Ho; Park, Tae Chul; Park, Jong Sup; Bae, Seog Nyeon; Hur, Soo Young
• Is Part Of: International journal of gynecological cancer. Volume 22:Issue 4(2012)
• Page Start: 686
• Page End: 691
• Publication Date: 2012-05-01
• Subjects: Cervical cancer -- Lymphedema -- Incidence -- Risk factor; Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1097/IGC.0b013e3182466950
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Objective: This study aimed to determine the incidence and risk factors of lower-extremity lymphedema (LEL) in women who had radical surgery with or without adjuvant radiotherapy for International Federation of Gynecology and Obstetrics (FIGO) stage I to stage IIA cervical cancer. Methods: The medical records were reviewed retrospectively on patients with histologically confirmed FIGO stage I to IIA cervical cancer. Lower-extremity lymphedema–related medical problems such as peripheral vascular disease, congestive heart failure, or chronic renal disease were excluded. A logistic regression analysis was used to examine the relationship between variable clinical characteristics and development of LEL. Results: We evaluated 707 patients. Of the 707 patients evaluated, we excluded 92 patients who had received radiotherapy as the initial therapy and 19 patients with LEL related to medical problems. Seventy-five patients (12.6%) developed LEL. The incidence was high in patients with adjuvant radiotherapy (odds ratio, 3.47; 95% confidence interval, 2.086–5.788; P = 0.000), with 78.7% of the patients with LEL having developed the condition within 3 years after initial treatment. Conclusions: Adjuvant radiotherapy was significantly associated with development of LEL in women who had undergone radical surgery with lymphadenectomy for FIGO stage I to stage IIA cervical cancer. The possibility for the occurrence of LEL must be fully explained before treatment and patients should be provided with the appropriate preventive education. Further prospective studies are needed to confirm the incidence and risk factors for LEL.